DNER and B-cell chronic lymphocytic leukemia: We demonstrate that the pan-BET inhibitor OPN-51107 reshapes the leukemia microenvironment with marked reversal of immunosuppressive mechanisms inherent to CLL, thereby enhancing T cell function and promoting the maintenance of progenitor T cells, at least in part, through chromatin reorganization.